Exact Sciences Q3: Strong Growth & New Tests

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded10 Nov 2025

Publisherfeeds.acast.com ↗

Handlerec:2199007

Show notes

Exact Sciences Q3 results showcase impressive revenue growth and strong performance in core screening business, driven by increased Cologuard usage, care gap programs, and new ordering providers. Revenue of $850.7 million surpasses estimates by 5%, with adjusted earnings per share at $0.24, exceeding predictions. The company raises full-year revenue guidance to $3.23 billion. During the earnings call, analysts inquired about screening segment acceleration and Freenome partnership updates. Exact Sciences plans to finalize insurance contracts, monitor new test adoption, and execute cost-saving strategies, while keeping an eye on clinical study data and international expansion efforts.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.